Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 23 for “"Rofecoxib"”.

  1. The effectiveness of rofecoxib on post-endodontic pain.

    … to determine if pre-operative administration of rofecoxib would significantly reduce post-endodontic pain, when compared to ibuprofen. Twenty-one patients requiring conventional root canal therapy were evaluated. Each of these patients were diagnosed as having periapical pain. The patients …

    wvu Repository record for The effectiveness of rofecoxib on post-endodontic pain. (opens in a new tab)

  2. Synthesis of 123-Iodine Labeled Rofecoxib Analogues: Potential Nuclear Medicine Imaging Agents

    … introduction ofa radiolabeled pharmaceutical. Rofecoxib (4-[ 4-methylsulphonylphenyl]-3phenylfuran-2(S<em>H</em>)-one) is an inhibitor of the cycloxygenase-2 enzyme, an enzyme which has been found to promote cancer cell growth. The synthesis of a no-carrier-added iodine-123 labeled rofecoxib …

    ut-knoxville Repository record for Synthesis of 123-Iodine Labeled Rofecoxib Analogues: Potential Nuclear Medicine Imaging Agents (opens in a new tab)

  3. Estudio experimental de quimioprevención del cáncer colorrectal con el inhibidor específico de la ciclooxigenasa-2, rofecoxib

    … Y MÉTODOS. Este trabajo estudia los efectos del Rofecoxib como inhibidor en un modelo experimental de carcinogénesis Colorrectal, induciéndolo con Azoximetano con tres dosis distintas en animales de experimentación (88 ratas Wistar). El estudio se ha realizado durante 52 semanas, administrando el …

    sevilla Repository record for Estudio experimental de quimioprevención del cáncer colorrectal con el inhibidor específico de la ciclooxigenasa-2, rofecoxib (opens in a new tab)

  4. Φαρμακοκινητική μελέτη και τοξικότητα των COX-2 αναστολέων στο καρδιαγγειακό σύστημα επιμύων

    … time. In our study we tried to determinate rofecoxib concentration in rat blood serum after subcutaneous administration of rofecoxib in four groups of male Wistar rats at a dose of 25mg/kg W.B once daily, for 10, 20, 30 and 45 days. The other four groups received vehicle. In the …

    greece Repository record for Φαρμακοκινητική μελέτη και τοξικότητα των COX-2 αναστολέων στο καρδιαγγειακό σύστημα επιμύων (opens in a new tab)

  5. Evidence Based Assessment of the Cardiovascular Adverse Effects of Specific Cyclooxy-Genase-2 Inhibitors

    … of the cardiovascular and related safety of rofecoxib for its licensed long-term indications. Method : Systematically search Pubmed, Cochrane, FDA, NICE, EULAR, CCOHTA, to identify systematic reviews concerning rofecoxib’s cardiovascular toxicity. The resulting set of citations was hand …

    aston Repository record for Evidence Based Assessment of the Cardiovascular Adverse Effects of Specific Cyclooxy-Genase-2 Inhibitors (opens in a new tab) Download PDF for Evidence Based Assessment of the Cardiovascular Adverse Effects of Specific Cyclooxy-Genase-2 Inhibitors (opens in a new tab)

  6. The relationship between Cox-2 inhibitors and cardiovascular risk: a retrospective analysis using the Veteran Affairs (VA) database

    … 35 years of age and older receiving celecoxib, rofecoxib, ibuprofen, etodolac, and naproxen from January 1, 1999 through December 31, 2001, were included. Multivariate Cox proportional hazard models were used to analyze the relationship between cardiovascular risk and NSAID/COX-2 inhibitor use …

    texas Repository record for The relationship between Cox-2 inhibitors and cardiovascular risk: a retrospective analysis using the Veteran Affairs (VA) database (opens in a new tab)

  7. Cardiovascular risk comparisons of non-steroidal anti-inflammatory agents in the TRICARE population

    … between the cyclooxygenase-2 (COX-2) inhibitors Rofecoxib, Celecoxib, and Valdecoxib, and the traditional nonsteroidal anti-inflammatory agents (NSAIDs) Naproxen and Ibuprofen, as well as Meloxicam, a preferential COX-2 inhibitor. The population studied was the DoD TRICARE beneficiary population …

    nps Repository record for Cardiovascular risk comparisons of non-steroidal anti-inflammatory agents in the TRICARE population (opens in a new tab)

  8. Untersuchung des tatsächlichen Einflusses häufig angewandter nichtsteroidaler Antiphlogistika auf die Thrombozytenfunktion

    … Diclofenac und der selektive COX-2 Hemmer Rofecoxib. Zunächst wurde an Tag 0 die Thrombozytenfunktion der Probanden ohne Einfluss eines Medikamentes gemessen. An Tag 1, 2 und 3 nahmen die Probanden eines der genannten Medikamente ein. An Tag 4, 5 und 6 wurde die Thrombozytenfunktion im …

    lmu-germany Repository record for Untersuchung des tatsächlichen Einflusses häufig angewandter nichtsteroidaler Antiphlogistika auf die Thrombozytenfunktion (opens in a new tab)

  9. Publication Bias: Assessment and Impact

    … it to two case studies: rosiglitazone and rofecoxib. For rosiglitazone we found that this unpublished research resulted in significant wasted drug spend but no clinical events. For rofecoxib, publication bias was found not to affect decision making.

    washington Repository record for Publication Bias: Assessment and Impact (opens in a new tab)

  10. Reduction of post-surgical pericardial adhesions using a pig model

    … two received indomethacin, Group three received rofecoxib (also a NSAID) and a polyethyleneglycol (Co-Seal) was applied to the pericardium as a barrier in Group four. After performing a median sternotomy, an adhesion induction model was applied to maximize inflammation in the pericardium. This …

    jamescook Download PDF for Reduction of post-surgical pericardial adhesions using a pig model (opens in a new tab)

  11. Studies on pain management: Preemptive analgesia and traditional Chinese medicine (TCM)

    … efficacies and safety profiles of preoperative rofecoxib and tramadol were compared in patients undergoing haemorrhoidectomies. They showed comparable analgesic efficacies, but tramadol was associated with higher incidence of side-effects. The questionnaire survey revealed that the prevalence of …

    nus Repository record for Studies on pain management: Preemptive analgesia and traditional Chinese medicine (TCM) (opens in a new tab) Download file for Studies on pain management: Preemptive analgesia and traditional Chinese medicine (TCM) (opens in a new tab)

  12. Pharmakologische Modulation der Ionenkanäle TRPV2, TRPV3 und TRPV4

    … durch andere COX-2-Hemmer, konkret Deracoxib und Rofecoxib, hervorgerufen werden kann. Für Rofecoxib wurde kein Einfluss auf TRPV3-Ionenkanäle detektiert. Deracoxib führte zu einer im Vergleich zu Valdecoxib sogar noch stärkeren Potenzierung des 2-APB-getriggerten, TRPV3-vermittelten Anstiegs der …

    qucosa-diss

  13. Risk-benefit tradeoffs for NSAIDs for the management of rheumatoid arthritis (RA)- a discrete choice experiment (DCE)

    … those with RA, nonselective NSAIDs and coxibs. Rofecoxib, is a coxib that was taken off the market due to evidence of an increased risk of cardiovascular events from the use of this drug relative to placebo. However, there are those who benefited from this drug and were willing to take the risk. …

    ubc Repository record for Risk-benefit tradeoffs for NSAIDs for the management of rheumatoid arthritis (RA)- a discrete choice experiment (DCE) (opens in a new tab) Download PDF for Risk-benefit tradeoffs for NSAIDs for the management of rheumatoid arthritis (RA)- a discrete choice experiment (DCE) (opens in a new tab)

  14. Triagem de alvos terapêuticos farmacológicos para prevenção da sensibilidade ao clareamento dentário a partir da inibição da síntese do óxido nítrico: estudo in silico

    … ibuprofen, nimesulide, naproxen sodium, rofecoxib, valdecoxib, prednisone and prednisolone were evaluated to investigate their affinities and potential modulating effects on the studied molecular targets. Aminoguanidine and dexamethasone were adopted as positive controls. The …

    brazil-ufrn Repository record for Triagem de alvos terapêuticos farmacológicos para prevenção da sensibilidade ao clareamento dentário a partir da inibição da síntese do óxido nítrico: estudo in silico (opens in a new tab) Embargoed until 2027-09-02

  15. Non steroidal anti-inflammatory drugs and cardiovascular risk: identifying evidence for channelling bias in a population based study

    … stable until 2004 when the COX-2 selective agent rofecoxib was withdrawn from the market. Following this date (i.e., September 30, 2004), the use of Diclo-Miso and single-entity diclofenac appeared to follow different trends. However, available patient and disease specific factors could not …

    sask Repository record for Non steroidal anti-inflammatory drugs and cardiovascular risk: identifying evidence for channelling bias in a population based study (opens in a new tab)

  16. Consecuencias de la inhibición de la ciclooxigenasa-2 en modelos experimentales de inflamación intestinal: Mecanismos moleculares implicados

    … valdecoxib, parecoxib, etoricoxib, celecoxib y rofecoxib. Estos cuatro últimos han sido comercializados en España, aunque la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), a solicitud del laboratorio titular, y en coordinación con el resto de agencias de la Unión Europea, ha …

    sevilla Repository record for Consecuencias de la inhibición de la ciclooxigenasa-2 en modelos experimentales de inflamación intestinal: Mecanismos moleculares implicados (opens in a new tab)

  17. Effect of lawsuits on stock price compared to product withdrawal: a focus on the consequences of Vioxx's adverse effects

    Pharmaceutical companies are plagued with lawsuits in today’s society. Some companies will hastily remove a product from the market before the negative side effects of the drug can be fully established for fear of severe losses due to lawsuits. Lawsuits will occur whether the drug is left on the …

    ttu Repository record for Effect of lawsuits on stock price compared to product withdrawal: a focus on the consequences of Vioxx's adverse effects (opens in a new tab)

Page 1 of 2